No Data
Oppenheimer Maintains Corvus Pharmaceuticals(CRVS.US) With Buy Rating, Maintains Target Price $15
Is Corvus Pharmaceuticals, Inc. (CRVS) the Best Multibagger Penny Stock to Buy According to Billionaires?
Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.
① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.
Express News | Corvus Pharmaceuticals Appoints Richard a. Van Den Broek to Board of Directors
Press Release: Corvus Pharmaceuticals Appoints Richard A. Van Den Broek to Board of Directors
Express News | Corvus Pharmaceuticals Shares Are Trading Lower After the Company Reported Q4 Financial Results and Missed Its EPS Estimate
scam stay away